Co-Authors
This is a "connection" page, showing publications co-authored by Marta Crespo and Julio Pascual.
Connection Strength
5.640
-
COVID-19 in elderly kidney transplant recipients. Am J Transplant. 2020 10; 20(10):2883-2889.
Score: 0.891
-
Mortality in Hemodialysis Patients with COVID-19, the Effect of Paricalcitol or Calcimimetics. Nutrients. 2021 Jul 26; 13(8).
Score: 0.240
-
Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19. Kidney Int Rep. 2021 Sep; 6(9):2305-2315.
Score: 0.239
-
Outcomes of COVID-19 Among Hospitalized Patients With Non-dialysis CKD. Front Med (Lausanne). 2020; 7:615312.
Score: 0.229
-
Respiratory and Gastrointestinal COVID-19 Phenotypes in Kidney Transplant Recipients. Transplantation. 2020 11; 104(11):2225-2233.
Score: 0.228
-
COVID-19 in Grade 4-5 Chronic Kidney Disease Patients. Kidney Blood Press Res. 2020; 45(5):768-774.
Score: 0.225
-
Clinical Profiles in Renal Patients with COVID-19. J Clin Med. 2020 Aug 18; 9(8).
Score: 0.225
-
[Protection of nephrology health professionals during the COVID-19 pandemic]. Nefrologia (Engl Ed). 2020 Jul - Aug; 40(4):395-402.
Score: 0.223
-
COVID-19-related Mortality During the First 60 Days After Kidney Transplantation. Eur Urol. 2020 10; 78(4):641-643.
Score: 0.222
-
[Management of the SARS-CoV-2 (COVID-19) coronavirus epidemic in hemodialysis units]. Nefrologia (Engl Ed). 2020 May - Jun; 40(3):258-264.
Score: 0.219
-
Mammalian Target of Rapamycin Inhibitors Combined With Calcineurin Inhibitors as Initial Immunosuppression in Renal Transplantation: A Meta-analysis. Transplantation. 2019 10; 103(10):2031-2056.
Score: 0.211
-
Gender differences in cancer risk after kidney transplantation. Oncotarget. 2019 May 03; 10(33):3114-3128.
Score: 0.205
-
Membrane Attack Complex and Factor H in Humans with Acute Kidney Injury. Kidney Blood Press Res. 2018; 43(5):1655-1665.
Score: 0.198
-
Factors associated with renal function compensation after donor nephrectomy. Nefrologia (Engl Ed). 2018 Sep - Oct; 38(5):528-534.
Score: 0.196
-
Maintenance low dose systemic glucocorticoids have limited impact on bone strength and mineral density among incident renal allograft recipients: A pilot prospective cohort study. Bone. 2018 11; 116:290-294.
Score: 0.196
-
Usefulness of the KDPI in Spain: A comparison with donor age and definition of standard/expanded criteria donor. Nefrologia (Engl Ed). 2018 Sep - Oct; 38(5):503-513.
Score: 0.193
-
Dual kidney transplantation as a strategy to use expanded criteria donors: a systematic review. Transpl Int. 2018 08; 31(8):838-860.
Score: 0.191
-
Impact of persistent and cleared preformed HLA DSA on kidney transplant outcomes. Hum Immunol. 2018 Jun; 79(6):424-431.
Score: 0.189
-
Erratum to "Renal graft survival according to Banff 2013 classification in indication biopsies". Nefrologia. 2017 May - Jun; 37(3):355.
Score: 0.179
-
MDRD or CKD-EPI for glomerular filtration rate estimation in living kidney donors. Nefrologia (Engl Ed). 2018 Mar - Apr; 38(2):207-212.
Score: 0.178
-
Strategies for an Expanded Use of Kidneys From Elderly Donors. Transplantation. 2017 Apr; 101(4):727-745.
Score: 0.178
-
Dual Role of Natural Killer Cells on Graft Rejection and Control of Cytomegalovirus Infection in Renal Transplantation. Front Immunol. 2017; 8:166.
Score: 0.176
-
Invasive aspergillosis in kidney transplant recipients: a cohort study. Exp Clin Transplant. 2014 Apr; 12(2):101-5.
Score: 0.144
-
Impact of a Nosocomial COVID-19 Outbreak on a Non-COVID-19 Nephrology Ward during the First Wave of the Pandemic in Spain. Antibiotics (Basel). 2021 May 22; 10(6).
Score: 0.059
-
Predictors of severe COVID-19 in kidney transplant recipients in the different epidemic waves: Analysis of the Spanish Registry. Am J Transplant. 2021 07; 21(7):2573-2582.
Score: 0.059
-
Use of tocilizumab in kidney transplant recipients with COVID-19. Am J Transplant. 2020 11; 20(11):3182-3190.
Score: 0.056
-
mTOR intersects antibody-inducing signals from TACI in marginal zone B cells. Nat Commun. 2017 11 13; 8(1):1462.
Score: 0.046
-
Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial. Am J Transplant. 2018 04; 18(4):927-935.
Score: 0.046